Last updated on 8 Sept 2023
Owner Info
Alnylam Pharmaceuticals, Inc.
300 Third Street
Cambridge MA 02142, UNITED STATES OF AMERICA
Serial Number
2008381 filed on 29 Mar 2019
Correspondent
Timothy H. Hiebert
Womble Bond Dickinson (US) LLP,
470 Atlantic Avenue, Suite 600,
UNITED STATES OF AMERICA
2008381
29 Mar 2019
NA
WORD
22 Mar 2019
US
Status Date | Action Taken |
---|---|
8th Sept 2023 | Status change to Voided |
30th Jul 2020 | Amendment to International Registration Contact Requested |
16th Nov 2019 | International Registration in Australia Protected correspondence sent |
15th Nov 2019 | IP Right Registration Published |
15th Nov 2019 | Status change to Registered/Protected |
9th Sept 2019 | Application Accepted correspondence sent |
8th Sept 2019 | IP Right Acceptance Published |
8th Sept 2019 | IP Right has been Examined |
8th Sept 2019 | Status change to Accepted |
10th May 2019 | Awaiting examination |